USD 21.13
(-0.19%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 | 855 Thousand USD | -103.26% |
2023 | 350.53 Million USD | -12.62% |
2022 | 401.14 Million USD | 2.19% |
2021 | 392.53 Million USD | 936.09% |
2020 | 37.88 Million USD | 135.26% |
2019 | -107.44 Million USD | -137.84% |
2018 | -45.17 Million USD | -158.26% |
2017 | 77.53 Million USD | 133.79% |
2016 | -229.47 Million USD | -78.46% |
2015 | -128.58 Million USD | -31.16% |
2014 | -98.03 Million USD | 40.1% |
2013 | -163.67 Million USD | -41.79% |
2012 | -115.43 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | 696.19 Million USD | 443.8% |
2024 Q4 | 855 Thousand USD | -99.88% |
2024 Q2 | -202.49 Million USD | 21.11% |
2024 FY | 855 Thousand USD | -99.76% |
2024 Q1 | -256.69 Million USD | -173.23% |
2023 Q1 | 381.54 Million USD | -4.89% |
2023 FY | 350.53 Million USD | -12.62% |
2023 Q3 | 397.06 Million USD | -18.32% |
2023 Q4 | 350.53 Million USD | -11.72% |
2023 Q2 | 486.14 Million USD | 27.41% |
2022 Q2 | 430.14 Million USD | 5.31% |
2022 Q4 | 401.14 Million USD | -7.71% |
2022 FY | 401.14 Million USD | 2.19% |
2022 Q1 | 408.43 Million USD | 4.05% |
2022 Q3 | 434.66 Million USD | 1.05% |
2021 Q1 | 528.1 Million USD | 1293.94% |
2021 FY | 392.53 Million USD | 936.09% |
2021 Q4 | 392.53 Million USD | -27.44% |
2021 Q3 | 541 Million USD | 9.75% |
2021 Q2 | 492.95 Million USD | -6.66% |
2020 Q4 | 37.88 Million USD | -48.23% |
2020 Q3 | 73.17 Million USD | 31038.3% |
2020 Q2 | 235 Thousand USD | 100.39% |
2020 FY | 37.88 Million USD | 135.26% |
2020 Q1 | -60.49 Million USD | 43.7% |
2019 Q2 | -3.17 Million USD | 90.98% |
2019 FY | -107.44 Million USD | -137.84% |
2019 Q4 | -107.44 Million USD | -618.5% |
2019 Q1 | -35.2 Million USD | 22.07% |
2019 Q3 | 20.72 Million USD | 752.66% |
2018 Q3 | 57.8 Million USD | 29.41% |
2018 Q2 | 44.66 Million USD | -5.32% |
2018 Q1 | 47.17 Million USD | -39.15% |
2018 FY | -45.17 Million USD | -158.26% |
2018 Q4 | -45.17 Million USD | -178.15% |
2017 Q2 | 126.61 Million USD | 192.49% |
2017 FY | 77.53 Million USD | 133.79% |
2017 Q3 | 147.42 Million USD | 16.43% |
2017 Q1 | -136.88 Million USD | 40.35% |
2017 Q4 | 77.53 Million USD | -47.4% |
2016 Q1 | 58.14 Million USD | 145.22% |
2016 Q2 | -40.26 Million USD | -169.24% |
2016 Q4 | -229.47 Million USD | -35.46% |
2016 FY | -229.47 Million USD | -78.46% |
2016 Q3 | -169.41 Million USD | -320.79% |
2015 Q3 | -135.27 Million USD | -42.34% |
2015 FY | -128.58 Million USD | -31.16% |
2015 Q2 | -95.03 Million USD | -59.93% |
2015 Q4 | -128.58 Million USD | 4.94% |
2015 Q1 | -59.42 Million USD | 39.39% |
2014 Q1 | 23.88 Million USD | 114.59% |
2014 Q3 | -114.28 Million USD | 3.04% |
2014 FY | -98.03 Million USD | 40.1% |
2014 Q4 | -98.03 Million USD | 14.21% |
2014 Q2 | -117.87 Million USD | -593.43% |
2013 Q4 | -163.67 Million USD | -118.96% |
2013 Q3 | -74.75 Million USD | 0.0% |
2013 FY | -163.67 Million USD | -41.79% |
2012 FY | -115.43 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Inovalon Holdings, Inc. | 773.42 Million USD | 99.889% |
GE HealthCare Technologies Inc. | 7.36 Billion USD | 99.988% |
Sharecare, Inc. | -125.84 Million USD | 100.679% |
Progyny, Inc. | -77.9 Million USD | 101.097% |
Aclarion, Inc. | 94.65 Thousand USD | -803.28% |
CareMax, Inc. | 426.4 Million USD | 99.799% |
Simulations Plus, Inc. | -9.83 Million USD | 108.693% |
CareCloud, Inc. | 11.4 Million USD | 92.501% |
Forian Inc. | 16.95 Million USD | 94.958% |
Bullfrog AI Holdings, Inc. Warrants | -2.62 Million USD | 132.575% |
Bullfrog AI Holdings, Inc. Common Stock | -2.62 Million USD | 132.575% |
Minerva Surgical, Inc. | 32.74 Million USD | 97.389% |
Omnicell, Inc. | 113.11 Million USD | 99.244% |
Definitive Healthcare Corp. | 136.95 Million USD | 99.376% |
Zhongchao Inc. | -6.74 Million USD | 112.684% |
Accolade, Inc. | 55.93 Million USD | 98.471% |
Streamline Health Solutions, Inc. | 7.37 Million USD | 88.408% |
Ontrak, Inc. | -8.01 Million USD | 110.671% |
SOPHiA GENETICS SA | -104.65 Million USD | 100.817% |
R1 RCM Inc. | 1.56 Billion USD | 99.945% |
Spok Holdings, Inc. | -20.9 Million USD | 104.09% |
Privia Health Group, Inc. | -381.22 Million USD | 100.224% |
EUDA Health Holdings Limited | 3.18 Million USD | 73.16% |
HeartBeam, Inc. | -16.18 Million USD | 105.281% |
GeneDx Holdings Corp. | 20.08 Million USD | 95.744% |
TruBridge, Inc. | 199.44 Million USD | 99.571% |
Nutex Health, Inc. | 253.75 Million USD | 99.663% |
Renalytix Plc | 3.85 Million USD | 77.821% |
Sharecare, Inc. | -125.84 Million USD | 100.679% |
Health Catalyst, Inc. | 142.79 Million USD | 99.401% |
10x Genomics, Inc. | -263.91 Million USD | 100.324% |
GoodRx Holdings, Inc. | 38.77 Million USD | 97.795% |
SCWorx Corp. | -1077.00 USD | 79487.187% |
Schrödinger, Inc. | -33.18 Million USD | 102.577% |
HealthEquity, Inc. | 529.16 Million USD | 99.838% |
HealthStream, Inc. | -17.11 Million USD | 104.996% |
MSP Recovery, Inc. | 667.69 Million USD | 99.872% |
Augmedix, Inc. | -20.49 Million USD | 104.172% |
BrightSpring Health Services, Inc. Common Stock | 3.65 Billion USD | 99.977% |
Ontrak, Inc. | -8.01 Million USD | 110.671% |
SHL Telemedicine Ltd. | 13.15 Million USD | 93.502% |
CareCloud, Inc. | 11.4 Million USD | 92.501% |
Certara, Inc. | 63.24 Million USD | 98.648% |
GeneDx Holdings Corp. | 20.08 Million USD | 95.744% |
OneMedNet Corporation | 5.05 Million USD | 83.084% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 3.65 Billion USD | 99.977% |
EUDA Health Holdings Limited | 3.18 Million USD | 73.16% |
HeartBeam, Inc. | -16.18 Million USD | 105.281% |
CareCloud, Inc. | 11.4 Million USD | 92.501% |
Mangoceuticals, Inc. | -610.32 Thousand USD | 240.089% |
CareMax, Inc. | 426.4 Million USD | 99.799% |
Healthcare Triangle, Inc. | 3.08 Million USD | 72.267% |
National Research Corporation | 32.3 Million USD | 97.353% |
Aclarion, Inc. | 94.65 Thousand USD | -803.28% |
OptimizeRx Corporation | 22.97 Million USD | 96.278% |